Objective To approach the mechanism of action of anticancer and the investigation progress of protein tyrosine kinase (PTK).
目的探讨蛋白酪氨酸激酶抑制剂抗肿瘤作用机理及其研究进展。
JAK2 is a constitutive protein tyrosine kinase (PTK) which can activate JAK-STAT signaling.
JAK2是一种组成性酪氨酸激酶，能激活JAK - STAT信号传导途径。
JAK2 is a constitutive protein tyrosine kinase (PTK) which can activate JAK-STAT signaling.
JAK2是一种组成性酪氨酸激酶，能激活JAK - STAT信号传导途径。
应用推荐